Terms: = Ovarian cancer AND Ki-67 AND Prognosis
150 results:
1. Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient.
Bhaskari J; Bhagat R; Shilpa V; Premalata CS; Krishnamoorthy L
J Ovarian Res; 2024 Apr; 17(1):77. PubMed ID: 38594780
[TBL] [Abstract] [Full Text] [Related]
2. Survival time prediction in patients with high-grade serous ovarian cancer based on
He D; Zhang X; Chang Z; Liu Z; Li B
BMC Cancer; 2024 Mar; 24(1):337. PubMed ID: 38475819
[TBL] [Abstract] [Full Text] [Related]
3. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
[TBL] [Abstract] [Full Text] [Related]
4. Fortuitously detected primary ovarian carcinoid tumor: A case report.
Choi HY; Pak MG; Park JW
Medicine (Baltimore); 2023 Aug; 102(31):e34391. PubMed ID: 37543794
[TBL] [Abstract] [Full Text] [Related]
5. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.
Jung D; Almstedt K; Battista MJ; Seeger A; Jäkel J; Brenner W; Hasenburg A
J Ovarian Res; 2023 Mar; 16(1):50. PubMed ID: 36869369
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells.
Wang YJ; Tang L; Lu XH; Liu JT; Wang YY; Geng HX; Li XT; An Q
J Liposome Res; 2023 Jun; 33(2):197-213. PubMed ID: 36440599
[TBL] [Abstract] [Full Text] [Related]
8. Novel Platinum Nanoclusters Activate PI3K/AKT/mTOR Signaling Pathway-Mediated Autophagy for Cisplatin-Resistant ovarian cancer Therapy.
Zhang M; Yue H; Huang X; Wang J; Li Z; Deng X
ACS Appl Mater Interfaces; 2022 Nov; 14(43):48502-48514. PubMed ID: 36261925
[TBL] [Abstract] [Full Text] [Related]
9. The analysis of hormonal status and vascular and cell proliferation in endometrioid endometrial adenocarcinomas.
Drocaş I; Crăiţoiu Ş; Stepan AE; Iliescu DG; Drocaş IA; Stepan MD
Rom J Morphol Embryol; 2022; 63(1):113-120. PubMed ID: 36074674
[TBL] [Abstract] [Full Text] [Related]
10. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract] [Full Text] [Related]
11. Understanding the Correlation between Metabolic Regulator SIRT1 and Exosomes with CA-125 in ovarian cancer: A Clinicopathological Study.
Roy S; Das A; Vernekar M; Mandal S; Chatterjee N
Biomed Res Int; 2022; 2022():5346091. PubMed ID: 35496046
[TBL] [Abstract] [Full Text] [Related]
12. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
Zhang L; Chen H; Ding B; Jiang W
J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
[TBL] [Abstract] [Full Text] [Related]
13. An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis.
Kusumoto S; Kurashige M; Ohshima K; Tahara S; Matsui T; Nojima S; Hattori S; Morii E
Cancer Med; 2021 Mar; 10(5):1485-1500. PubMed ID: 33611864
[TBL] [Abstract] [Full Text] [Related]
14. miR-497-5p Decreased Expression Associated with High-Risk Endometrial cancer.
Fridrichova I; Kalinkova L; Karhanek M; Smolkova B; Machalekova K; Wachsmannova L; Nikolaieva N; Kajo K
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374439
[TBL] [Abstract] [Full Text] [Related]
15. ovarian fibrosarcoma: A single-institution experience and a review of the literature.
Sun TT; Cheng NH; Cao DY; Peng P
J Ovarian Res; 2020 Dec; 13(1):142. PubMed ID: 33292402
[TBL] [Abstract] [Full Text] [Related]
16. Lymphovascular space invasion and Ki67 as predictors of lymph node metastasis in primary low grade serous ovarian cancer.
Grabowski JP; Glajzer J; Richter R; Plett H; Muallem MZ; Braicu EI; Taube E; Sehouli J
Int J Gynecol Cancer; 2021 Jan; 31(1):98-103. PubMed ID: 33127866
[TBL] [Abstract] [Full Text] [Related]
17. Impact of ki-67 Labeling Index on Prognostic Significance of the Chemotherapy Response Score in Women With Tubo-ovarian cancer Treated With Neoadjuvant Chemotherapy.
Heayn M; Skvarca LB; Zhu L; Edwards RP; Olawaiye AB; Modugno F; Elishaev E; Bhargava R
Int J Gynecol Pathol; 2021 May; 40(3):278-285. PubMed ID: 32897953
[TBL] [Abstract] [Full Text] [Related]
18. High amplification of PVT1 and MYC predict favorable prognosis in early ovarian carcinoma.
Yamamoto A; Kurata M; Yamamoto K; Nogawa D; Inoue M; Ishibashi S; Ikeda M; Miyasaka N; Kitagawa M
Pathol Res Pract; 2020 Nov; 216(11):153175. PubMed ID: 32841774
[TBL] [Abstract] [Full Text] [Related]
19. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
20. Prognostic Role of Krüppel-Like Factors 5, 9, and 11 in Endometrial Endometrioid cancer.
Viola L; Londero AP; Bertozzi S; Orsaria M; Marzinotto S; Antoniazzi F; Renda V; Cinel J; Fruscalzo A; Lellé RJ; Mariuzzi L
Pathol Oncol Res; 2020 Oct; 26(4):2265-2272. PubMed ID: 32451988
[TBL] [Abstract] [Full Text] [Related]
[Next]